Evidence map›Paper›PMID 39944294›Full record

ArticleRoyal Society open science2025

Novel, nanomagnetic and recoverable copper(0)-catalyst in one-pot access to 1,4-disubstituted 1,2,3-triazoles and 5-substituted 1

Mohammad Amiri, Nastaran Bagherzadeh, Ali Reza Sardarian

Abstract read
In one paragraph

Article in Royal Society open science, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Mohammad AmiriChemistry Department, College of Science, Shiraz University, Shiraz, Fars, Iran.
Nastaran BagherzadehChemistry Department, College of Science, Shiraz University, Shiraz, Fars, Iran.
Ali Reza SardarianChemistry Department, College of Science, Shiraz University, Shiraz, Fars, Iran.ORCID https://orcid.org/0000-0003-4407-2527

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A novel Fe

Indexed as

1,4-disubstituted-1,2,3-triazoles5-substituted 1H-tetrazolesaqueous mediaheterogeneous nanocatalyst Cu(0)

Identifiers

PMID39944294
PMCPMC11814627

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.